Peter Przeradzki LMSW

Recommended Articles

• Fecal Microbiota Transplant Is Safe and Effective for Ulcerative Colitis Treatment

  People with ulcerative colitis understand the pain of going to the restroom. There are many people who do not understand the pain associated with this condition.But what if there was an opportunity for the intestinal tract to heal?We are talking about fecal microbiota transplants, and they may bring...

• A Cystic Fibrosis App to Bring Data to Market

  For many people with CF, remembering their daily treatment regimens and medication schedules can seem daunting and difficult. Most patients acclaim that if they had a resource, such as an app, that would make their health management easier to handle, that they would love to try it. In addition to...

• Gum Disease May Appear in Young Adults

  According to a study conducted by the researchers from dentistry school of the University of North Carolina at Chapel Hill, gum disease may start earlier than expected. Young adults should take better care of their oral health, as it may lead to many health problems. The study shows that gum disease...

• What Are The Risks For Atrial Fibrillation Surgery?

  What Are The Risks For Atrial Fibrillation Surgery?Atrial fibrillation or A – Fib is an infection that causes abnormal heartbeat rhythms. As a result of this, the heart beating is not normal. Due to this abnormal heart beat, arrhythmia’s (Fast or Slow heartbeat) may develop. The most affected...

• Massachusetts Company Cannot Fire Worker for Using Medical Marijuana in Crohn’s Disease Management

  The potential legalization of marijuana has been a "hot topic" for some years now, as certain states make moves for legalization and even more have approved the use of medical marijuana. However, not all employers necessarily condone those who work for them using the drug, even for medical purposes....

• New Treatment for Celiac Disease Using Nanoparticles Is Underway

  Recently, investigators have found a potential way to develop a treatment for celiac disease, which, according to Cour Pharmaceuticals focuses on the autoimmune disease, along with other inflammatory diseases. The treatment has been approved for clinical trials in August, 2017, and these trials have...